WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
Results showed the benefits of early initiation of WINREVAIR within the first year after PAH diagnosis HYPERION results were presented today at ERS 2025 and simultaneously... Read more.
E3 Lithium Enters Into Agreement to Sell Non-Core Saskatchewan Assets
Cash proceeds to enhance balance sheet and support Clearwater Project development CALGARY, Alberta–(BUSINESS WIRE)–E3 LITHIUM LTD. (TSXV: ETL) (FSE:... Read more.
Remastering an Icon: Introducing Logitech MX Master 4
The First MX Mouse with Haptics that Transforms Productivity Through Tactile Feedback Logitech’s only mouse with customizable haptics for professionals seeking... Read more.
SnapLogic and Antemia Partner to Advance Digital Lifecycle Integration for Engineering Enterprises
New collaboration connects product lifecycle management with AI-powered integration to accelerate innovation in automotive, pharma, aerospace, defense, and other... Read more.
Cybersecurity Wakeup: Gen Z Tops the List for Falling for Phishing Attacks
New survey from Yubico unveils a holistic picture of cybersecurity readiness across nine countries SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Regulatory... Read more.
Cybersecurity Wakeup: Gen Z Tops the List for Falling for Phishing Attacks
New survey from Yubico unveils a holistic picture of cybersecurity readiness across nine countries SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Amid... Read more.
UK IT Leaders Warn That Email Is the Front Door for Cyber Risk – and It’s Still Wide Open
The majority of UK IT leaders (83%) have faced an email-related security incident – with many warning organisations risk ending up in “Mail Jail” without... Read more.
Omdia: 5G Standalone Networks and RedCap Devices Poised to Transform IoT Landscape in 2025
LONDON–(BUSINESS WIRE)–#5G—New analysis from Omdia reveals that 2025 is set to be a breakout year for 5G Standalone (SA) network deployments and... Read more.
Endeavor BioMedicines Announces Publication of Positive Data from Phase 2a Trial in The Lancet Respiratory Medicine Evaluating taladegib (ENV-101) in Individuals with Idiopathic Pulmonary Fibrosis
Treatment with taladegib demonstrated improved lung function from baseline, increased total lung capacity and reversed key measures of lung fibrosis in patients... Read more.
Coty Announces Plans to Bolster Its Leading Position in Fragrance and Launches a Strategic Review of Its Consumer Beauty Business
Maximizes Growth Potential Through Closer Integration of Prestige and Mass Fragrances to Establish a Fragrance and Scenting Powerhouse with Consumer Reach from $5... Read more.